Oncoloxía médica
Servicio
KU Leuven
Lovaina, BélgicaPublicacións en colaboración con investigadores/as de KU Leuven (6)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
2021
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Nature Communications, Vol. 12, Núm. 1
2017
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2014
-
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Molecular Cancer, Vol. 13, Núm. 1
2013
-
Bevacizumab plus chemotherapy continued beyond first progression in patients withmetastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Annals of Oncology, Vol. 24, Núm. 9, pp. 2342-2349